Description

Thorotrast was a contrast agent used in radiology from 1930 to 1960 hat has been associated with liver and other tumors.


Chemical form: thorium dioxide

 

Mechanism of injury: alpha, beta and gamma radiation

 

Histologic features: refractile granules in macrophages (portal tract, other)

 

Radiographic features: metallic hyperdensities in liver, spleen and lymph nodes (RE system), with positive autoradiography

 

Tumors associated with thorotrast exposure:

(1) hepatic angiosarcoma

(2) cholangiocarcinoma

(3) hepatocellular carcinoma

(4) erythroleukemia or other leukemia

(5) carcinoma of the frontal sinus

 

Other lesions associated with thorotrast:

(1) hepatic nodular regenerative hyperplasia

(2) granuloma (thorotrastoma) at site of extravasation

 

Other pathologies:

(1) bone marrow hypoplasia with anemia

(2) myelofibrosis

(3) thyroid disease

(4) noncirrhotic portal hypertension

(5) pulmonary fibrosis


To read more or access our algorithms and calculators, please log in or register.